BACKGROUND: Widespread varicella vaccination has led to substantial decreases in varicella-related mortality and hospitalizations. The effect of the vaccine on ambulatory care utilization is poorly defined. OBJECTIVE: To determine trends in varicella-related ambulatory care and hospital discharges before and after vaccine licensure. DESIGN, SETTING, AND PARTICIPANTS: Estimates of varicella-related ambulatory and hospital discharges were calculated for the pre- (1993-1995) and post- (1996-2004) vaccine licensure periods using the National Ambulatory Medical Care Survey, National Hospital Ambulatory Medical Care Survey, and National Hospital Discharge Survey. MAIN OUTCOME MEASURE: Ambulatory and hospital discharge rates for varicella. RESULTS: The rate of varicella-related ambulatory discharges decreased by 66% from 106.6 per 100,000 (95% confidence interval [CI]: 80.5-132.6) in the prelicensure period to 36.4 per 100,000 population (95% CI: 29.3-43.5) in the post-licensure period (P < 0.001). The decrease was significant across all age groups <45 years, with the greatest reduction (98%) occurring among patients 0 to 4 years of age. The incidence of varicella-related hospital discharges decreased by 53% from 30.9 per 100,000 (95% CI: 24.4-37.3) to 14.5 per 100,000 population (95% CI: 12.1-16.8; P < 0.001). This difference was significant among patients <14 years of age. Rates of varicella-related ambulatory discharges decreased significantly for both whites and non-whites in the postlicensure period, but postlicensure ambulatory discharge rates remained higher for non-whites than for whites. Decreases in varicella-related hospital discharges were statistically significant for whites and non-whites. Racial differences in the incidence of varicella-related hospital discharges also persisted following vaccine licensure. CONCLUSIONS: Varicella-related ambulatory visits and hospitalizations have decreased significantly in the period after licensure of the varicella vaccine.
BACKGROUND: Widespread varicella vaccination has led to substantial decreases in varicella-related mortality and hospitalizations. The effect of the vaccine on ambulatory care utilization is poorly defined. OBJECTIVE: To determine trends in varicella-related ambulatory care and hospital discharges before and after vaccine licensure. DESIGN, SETTING, AND PARTICIPANTS: Estimates of varicella-related ambulatory and hospital discharges were calculated for the pre- (1993-1995) and post- (1996-2004) vaccine licensure periods using the National Ambulatory Medical Care Survey, National Hospital Ambulatory Medical Care Survey, and National Hospital Discharge Survey. MAIN OUTCOME MEASURE: Ambulatory and hospital discharge rates for varicella. RESULTS: The rate of varicella-related ambulatory discharges decreased by 66% from 106.6 per 100,000 (95% confidence interval [CI]: 80.5-132.6) in the prelicensure period to 36.4 per 100,000 population (95% CI: 29.3-43.5) in the post-licensure period (P < 0.001). The decrease was significant across all age groups <45 years, with the greatest reduction (98%) occurring among patients 0 to 4 years of age. The incidence of varicella-related hospital discharges decreased by 53% from 30.9 per 100,000 (95% CI: 24.4-37.3) to 14.5 per 100,000 population (95% CI: 12.1-16.8; P < 0.001). This difference was significant among patients <14 years of age. Rates of varicella-related ambulatory discharges decreased significantly for both whites and non-whites in the postlicensure period, but postlicensure ambulatory discharge rates remained higher for non-whites than for whites. Decreases in varicella-related hospital discharges were statistically significant for whites and non-whites. Racial differences in the incidence of varicella-related hospital discharges also persisted following vaccine licensure. CONCLUSIONS: Varicella-related ambulatory visits and hospitalizations have decreased significantly in the period after licensure of the varicella vaccine.
Authors: Barna D Tugwell; Lore E Lee; Hilary Gillette; Eileen M Lorber; Katrina Hedberg; Paul R Cieslak Journal: Pediatrics Date: 2004-03 Impact factor: 7.124
Authors: Jane F Seward; Barbara M Watson; Carol L Peterson; Laurene Mascola; Jan W Pelosi; John X Zhang; Teresa J Maupin; Gary S Goldman; Laura J Tabony; Kimberly G Brodovicz; Aisha O Jumaan; Melinda Wharton Journal: JAMA Date: 2002-02-06 Impact factor: 56.272
Authors: Philip L Gould; Jessica Leung; Connie Scott; D Scott Schmid; Helen Deng; Adriana Lopez; Sandra S Chaves; Meredith Reynolds; Linda Gladden; Rafael Harpaz; Sandra Snow Journal: Pediatr Infect Dis J Date: 2009-08 Impact factor: 2.129
Authors: Thomas R Talbot; Katherine A Poehling; Tina V Hartert; Patrick G Arbogast; Natasha B Halasa; Ed Mitchel; William Schaffner; Allen S Craig; Kathryn M Edwards; Marie R Griffin Journal: Pediatr Infect Dis J Date: 2004-08 Impact factor: 2.129
Authors: Paolo Bonanni; Anne Gershon; Michael Gershon; Andrea Kulcsár; Vassiliki Papaevangelou; Bernard Rentier; Catherine Sadzot-Delvaux; Vytautas Usonis; Timo Vesikari; Catherine Weil-Olivier; Peter de Winter; Peter Wutzler Journal: Pediatr Infect Dis J Date: 2013-07 Impact factor: 2.129
Authors: Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani Journal: Clin Microbiol Rev Date: 2013-07 Impact factor: 26.132